Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Cell Host & Microbe(2020)10.1016/j.chom.2020.11.012Source: DataRank Database

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization is a research paper published in Cell Host & Microbe (2020). On theSindex it has a DataRank of 0. It has been cited 354 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access354 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (26 grants)OA: bronzeTopics (79)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Mohamad‐Gabriel Alameh ORCID,Thushan I. de Silva ORCID,Paul Collini ORCID,Hailey Hornsby ORCID,Rebecca Brown ORCID

Live enrichment

PubMed:33306985 PMC:PMC7707640

National Institutes of Health

Grant: 75N93019C00050

National Institutes of Health

Grant: HHSN272201800004C

National Institutes of Health

Grant: R01 - AI145687

Wellcome Trust

Grant: 110058/Z/15/Z

National Institute of Allergy and Infectious Diseases

Grant: AI142596

National Institute of Allergy and Infectious Diseases

Grant: AI124429

National Institute of Allergy and Infectious Diseases

Grant: R01AI123738

National Institute of Allergy and Infectious Diseases

Grant: 1R01AI146101

Laboratory Directed Research and Development

Grant: 20200706ER

Bill and Melinda Gates Foundation

Grant: OPP1146996

NIAID NIH HHS

Grant: R01 AI124429

NIAID NIH HHS

Grant: R01 AI145687

NIAID NIH HHS

Grant: U19 AI142596

NIAID NIH HHS

Grant: R01 AI146101

NIAID NIH HHS

Grant: R37 AI150590

Wellcome Trust

Grant: 110058

Immunogenicity of intranasal live attenuated influenza vaccination (LAIV) and bidirectional interactions with the host microbiome.

National Institutes of Health

Grant: 1R01AI145687-01

Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection

National Institutes of Health

Grant: 5R01AI124429-03

Nucleoside modified mRNA based HIV vaccine

National Institutes of Health

Grant: 5R01AI123738-06

Cytokine regulation of T follicular helper (Tfh) cell biology

National Institutes of Health

Grant: 5U19AI142596-03

Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies

National Institutes of Health

Grant: 5R01AI146101-05

Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA

University of Pennsylvania

National Institute for Health Research (NIHR)

UK Research and Innovation

Wellcome Trust

bronzeLicense: Elsevier Non-Commercial

publisherhttp://www.cell.com/article/S193131282030634X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S193131282030634X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S193131282030634X?httpAccept=text/plain

repositoryhttps://www.osti.gov/biblio/1734731

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7707640

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciencesAdolescentAdultAnimalsAntibodies, MonoclonalBinding SitesCOVID-19COVID-19 VaccinesFemaleHEK293 CellsHumansImmunization, PassiveMacaca mulattaMaleMice, Inbred BALB CMiddle AgedMutationNeutralization TestsSARS-CoV-2Spike Glycoprotein, CoronavirusYoung AdultCOVID-19 SerotherapyMice

MeSH Terms

AnimalsMice, Inbred BALB CMacaca mulattaHumansMiceAntibodies, MonoclonalNeutralization TestsImmunization, PassiveBinding SitesMutationAdolescentAdultMiddle AgedFemaleMaleYoung AdultHEK293 CellsSpike Glycoprotein, CoronavirusCOVID-19SARS-CoV-2COVID-19 VaccinesCOVID-19 Serotherapy

Keywords

mRNAVaccineNeutralizationspikeLnpElectron MicrographCovid-19Sars-cov-2D614gNucleoside-modifiedAdultMaleCOVID-19 VaccinesAdolescentMicrobiologyYoung AdultShort ArticleNeutralization TestsVirologyAnimalsHumansMice, Inbred BALB CBinding SitesImmunization, PassiveAntibodies, MonoclonalMiddle AgedMacaca mulattaHEK293 CellsMutationSpike Glycoprotein, CoronavirusParasitologyFemale

Sustainable Development Goals

SDG 3: 3. Good health